Explorer

AIIMS To Begin Covid-19 Vaccine Human Trial From Next Week, To Start Registration Of Volunteers Shortly

AIIMS has also set up a dedicated email and phone number for the volunteers to register themselves for this project. The volunteers will have to undergo tests, which include Covid-19 test and also tests for other comorbidities.

New Delhi: In a major development, AIIMS Delhi will begin human trials of India's first indigenous Covid-19 vaccine, Covaxin, from next week on 100 healthy volunteers aged between 18 and 55. ALSO READ | Maharashtra Covid-19 Cases Cross 3 Lakh-Mark, Mumbai Tally Zooms Past 1 Lakh The volunteers will be kept under observation for a period of nearly 150 days. Covaxin is developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). According to Bharat Biotech, The Phase 1 clinical trial for Covaxin has been initiated across the country from July 15 onwards, and this is a randomised, double-blind, placebo-controlled clinical trial on 375 volunteers across the country. Speaking to IANS, Sanjay Rai, Professor of Community Medicine and Principal Investigator of Covid-19 vaccine trial at AIIMS, said, "We will begin human trials of India's first indigenous vaccine, Covaxin, on 100 healthy volunteers aged between 18 and 55 years. We will ensure that none of the volunteers have any comorbidities. AIIMS will conduct trials on 100 volunteers out of a total of 375 persons." ALSO READ | Community Transmission Of Covid-19 Has Started In India, Situation Is Bad: Indian Medical Association AIIMS has also set up a dedicated email and phone number for the volunteers to register themselves for this project. The volunteers will have to undergo tests, which include Covid-19 test and also tests for other comorbidities. If found healthy, they will be administered the vaccine. According to a senior official, recently the ethics committee has given a go-ahead for human trials for the vaccine, and AIIMS will begin registering volunteers as per the procedure. "After administering the vaccine, we will follow up with the volunteers through phone calls. They will be kept under observation for nearly 150 days," added Rai. Volunteers willing to register for human trials can email at ctaiims.covid19@gmail.com. ALSO READ | In A First, Kerala CM Confirms Community Transmission Of Covid-19 In State; Announces More Restrictions On Friday, Haryana Health Minister Anil Vij had said that human trial of a vaccine against novel coronavirus has begun at the Post Graduate Institute of Medical Sciences in Rohtak. "Three subjects have enrolled for the trial and tolerated the vaccine very well. There were no adverse effects," he said. The SARS-CoV-2 strain was isolated in NIV, Pune, and transferred to Bharat Biotech. The indigenous, inactivated vaccine was developed and manufactured in Bharat Biotech's BSL-3A (Bio-Safety Level 3) High Containment facility located in Genome Valley, Hyderabad. The Drug Controller General of India, Central Drugs Standard Control Organisation (CDSCO), and the Ministry of Health & Family Welfare granted permission to initiate Phase-I and II human clinical trials after the company submitted results generated from pre-clinical studies, demonstrating safety and immune response.

Check out below Health Tools-
Calculate Your Body Mass Index ( BMI )

Calculate The Age Through Age Calculator

View More
Advertisement
Advertisement
25°C
New Delhi
Rain: 100mm
Humidity: 97%
Wind: WNW 47km/h
See Today's Weather
powered by
Accu Weather
Advertisement

Top Headlines

Odd-Even Scheme In Delhi? Here's What Gopal Rai Said On Imposing The Scheme Amid Alarming Pollution Levels
Odd-Even In Delhi? Here's What Gopal Rai Said On Imposing Scheme Amid Alarming Pollution Levels
Delhi To Suspend Physical Classes For Class 10 And 12 Amid Pollution, Teaching To Go Online
Delhi To Suspend Physical Classes For Class 10 And 12 Amid Pollution, Teaching To Go Online
PM Modi Meets UK's Keir Starmer, French President Macron, discusses working closely in space & energy sectors
PM Modi Meets UK's Keir Starmer, French President Macron, discusses working closely in space & energy sectors
NCP (SP) Leader Anil Deshmukh Injured In Stone Pelting In Maharashtra's Katol, Rushed To Hospital
NCP (SP) Leader Anil Deshmukh Injured In Stone Pelting In Maharashtra's Katol, Rushed To Hospital
Advertisement
ABP Premium

Videos

Will We Get To Watch Gangs Of Wasseypur 3? Find Out from Writer-Actor Zeishan Quadri | ABP LiveJharkhand Report: Will Raj Sinha Secure a Hat-Trick This Time? How Much Benefit Will BJP Gain in Kolhan?Jharkhand Report: 'We Won't Let BJP Divide on Hindu-Muslim Lines,' Why Muslims in Jharkhand are Angry with BJPJharkhand Report: Jharia Public to Support Ragini, Ragini Singh Shares Plan to Win the Election

Photo Gallery

Embed widget